Literature DB >> 15518926

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.

Gillian M Tozer1, Simon M Ameer-Beg, Jennifer Baker, Paul R Barber, Sally A Hill, Richard J Hodgkiss, Rosalind Locke, Vivien E Prise, Ian Wilson, Borivoj Vojnovic.   

Abstract

The blood supply of solid tumours affects the outcome of treatment via its influence on the microenvironment of tumour cells and drug delivery. In addition, tumour blood vessels are an important target for cancer therapy. Intravital microscopy of tumours growing in 'window chambers' in animal models provides a means of directly investigating tumour angiogenesis and vascular response to treatment, in terms of both the morphology of blood vessel networks and the function of individual vessels. These techniques allow repeated measurements of the same tumour. Recently, multi-photon fluorescence microscopy techniques have been applied to these model systems to obtain 3D images of the tumour vasculature, whilst simultaneously avoiding some of the problems associated with the use of conventional fluorescence microscopy in living tissues. Here, we review the current status of this work and provide some examples of its use for studying the dynamics of tumour angiogenesis and vascular function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15518926     DOI: 10.1016/j.addr.2004.07.015

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  43 in total

1.  Two-photon fluorescence vascular bioimaging with new bioconjugate probes selective toward the vascular endothelial growth factor receptor 2.

Authors:  Carolina D Andrade; Ciceron O Yanez; Hyo-Yang Ahn; Takeo Urakami; Mykhailo V Bondar; Masanobu Komatsu; Kevin D Belfield
Journal:  Bioconjug Chem       Date:  2011-10-04       Impact factor: 4.774

2.  RGD-conjugated two-photon absorbing near-IR emitting fluorescent probes for tumor vasculature imaging.

Authors:  Xiling Yue; Alma R Morales; Grace W Githaiga; Adam W Woodward; Simon Tang; Junko Sawada; Masanobu Komatsu; Xuan Liu; Kevin D Belfield
Journal:  Org Biomol Chem       Date:  2015-11-21       Impact factor: 3.876

Review 3.  Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Authors:  Eugene Kim; Spyros Stamatelos; Jana Cebulla; Zaver M Bhujwalla; Aleksander S Popel; Arvind P Pathak
Journal:  Ann Biomed Eng       Date:  2012-05-08       Impact factor: 3.934

4.  Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging.

Authors:  Boguslaw Tomanek; Umar Iqbal; Barbara Blasiak; Abedelnasser Abulrob; Homam Albaghdadi; John R Matyas; Dragana Ponjevic; Garnette R Sutherland
Journal:  Neuro Oncol       Date:  2011-10-19       Impact factor: 12.300

Review 5.  Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.

Authors:  Chryso Kanthou; Gillian M Tozer
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 6.  Plasmonic nanoprobes: from chemical sensing to medical diagnostics and therapy.

Authors:  Tuan Vo-Dinh; Andrew M Fales; Guy D Griffin; Christopher G Khoury; Yang Liu; Hoan Ngo; Stephen J Norton; Janna K Register; Hsin-Neng Wang; Hsiangkuo Yuan
Journal:  Nanoscale       Date:  2013-09-20       Impact factor: 7.790

7.  Cholesterol superlattice modulates CA4P release from liposomes and CA4P cytotoxicity on mammary cancer cells.

Authors:  Berenice Venegas; Weiwei Zhu; Nicole B Haloupek; Janet Lee; Elizabeth Zellhart; István P Sugár; Mohammad F Kiani; Parkson Lee-Gau Chong
Journal:  Biophys J       Date:  2012-05-02       Impact factor: 4.033

8.  Deep in vivo two-photon imaging of blood vessels with a new dye encapsulated in pluronic nanomicelles.

Authors:  Mathieu Maurin; Olivier Stéphan; Jean-Claude Vial; Seth R Marder; Boudewijn van der Sanden
Journal:  J Biomed Opt       Date:  2011-03       Impact factor: 3.170

9.  Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad.

Authors:  Noa Madar-Balakirski; Catherine Tempel-Brami; Vyacheslav Kalchenko; Ori Brenner; David Varon; Avigdor Scherz; Yoram Salomon
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 10.  The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Authors:  Muireann T Kelleher; Gilbert Fruhwirth; Gargi Patel; Enyinnaya Ofo; Frederic Festy; Paul R Barber; Simon M Ameer-Beg; Borivoj Vojnovic; Cheryl Gillett; Anthony Coolen; György Kéri; Paul A Ellis; Tony Ng
Journal:  Target Oncol       Date:  2009-09-16       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.